Compared to healthy subjects or patients with MCI, patients with AD exhibit significantly elevated concentrations of IL-6, IL-1β, and TNF-α in both plasma and cerebrospinal fluid (Swardfager et al., 2010; Culjak et al., 2020). The gene discussed is IL6; the disease is Alzheimer disease.